Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunohistochemistry Market Trends and Forecast
3.3: Global Immunohistochemistry Market by Product
3.3.1: Antibodies
3.3.2: Reagents
3.3.3: Equipment
3.3.4: Kits
3.4: Global Immunohistochemistry Market by Application
3.4.1: Diagnostics
3.4.1.1: Cancer
3.4.1.2: Infectious
3.4.1.3: Nephrological Diseases
3.4.1.4: Autoimmune Diseases
3.4.1.5: Neurological Diseases
3.4.1.6: Other Diseases
3.4.2: Research
3.4.3: Forensic
3.5: Global Immunohistochemistry Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
3.5.3: Academic Institutes
3.5.4: Others
4. Market Trends and Forecast Analysis by Region
4.1: Global Immunohistochemistry Market by Region
4.2: North American Immunohistochemistry Market
4.2.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.2.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.2.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.2.4: The United States Immunohistochemistry Market
4.2.5: The Canadian Immunohistochemistry Market
4.2.6: The Mexican Immunohistochemistry Market
4.3: European Immunohistochemistry Market
4.3.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.3.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.3.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.3.4: The Immunohistochemistry Market of the United Kingdom
4.3.5: The Italian Immunohistochemistry Market
4.3.6: The German Immunohistochemistry Market
4.3.7: The French Immunohistochemistry Market
4.4: APAC Immunohistochemistry Market
4.4.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.4.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.4.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.4.4: The Chinese Immunohistochemistry Market
4.4.5: The Indian Immunohistochemistry Market
4.4.6: The Japanese Immunohistochemistry Market
4.5: ROW Immunohistochemistry Market
4.5.1: Market by Product: Antibodies, Reagents, Equipment, and Kits
4.5.2: Market by Application: Diagnostics (Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, and Other Diseases), Research, and Forensic
4.5.3: Market by End User: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
4.5.4: Brazilian Immunohistochemistry Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
7.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
7.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End User
7.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
7.2: Emerging Trends in the Global Immunohistochemistry Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunohistochemistry Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
7.3.4:Certification and Licensing
8. Company Profiles of Leading Players
8.1: F. Hoffmann-La Roche Ltd.
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: PHC Holding Corporation
8.5: Biocare Medical, LLC.
8.6: Merck KGaA
8.7: Bio-Rad Laboratories, Inc.
8.8: Bio-Techne Corporation
8.9: Abcam Plc
8.10: Becton, Dickinson And Company